AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition

Published: May 15, 2012

ALBANY, N.Y., May 15, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the Company's shareholders approved the issuance of approximately 9.5 million shares of AngioDynamics common stock for use in the acquisition of privately-held Navilyst Medical pursuant to the terms of the definitive acquisition agreement dated January 30, 2012. Ninety-three percent of the shares voted in favor of the share issuance at today's Special Meeting of Stockholders.

Back to news